Global Vascular Stents Market Report and Forecast 2024-2032

Global Vascular Stents Market Outlook

The global vascular stents market size reached a value of almost USD 10.57 billion in the year 2023. The vascular stents industry is further expected to grow at a CAGR of 5.5% between 2024 and 2032 to reach a value of almost USD 17.10 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The global vascular stents market is driven by increasing preference for minimally invasive (MI) procedures all over the world. North America is the leading market for vascular stents in the world. This can be ascribed to rising obesity, changing food consumption patterns, and a rise in smoking and alcohol consumption across the region.

Properties and Applications

Vascular diseases are those diseases that are caused by abnormalities in blood vessels that result in blockage or damage. Some of the common vascular diseases include abdominal aortic aneurysm (AAA), peripheral arterial disease (PAD), coronary heart disease, and carotid artery disease (CAD).

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The market is divided on the basis of type into:

• Coronary Stents
• Peripheral Vascular Stents
• EVAR Stent Grafts
• Others

Currently, the coronary type represents the most extensively used product type in the market.

On the basis of material, the market is segmented into:

• Metallic 
• Others

Metallic stents are further divided on the basis of type into cobalt chromium, platinum chromium, nickel titanium, and stainless steel.

On the basis of mode of delivery, the market is bifurcated into:

• Balloon-Expandable 
• Self-Expanding 

At present, balloon-expandable stents account for the majority of the total market share.

On the basis of end-uses, the market is divided into:

• Hospitals and Cardiac Centres Ambulatory Surgical Centres

Out of these, hospitals and cardiac centres hold the dominant market share.

The report also covers the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

The global vascular stents market is driven by the rising geriatric population across the globe. In addition to this, the rising incidences of coronary artery disease have led to the growing need for heart stent surgeries. This can be attributed to unhealthy eating habits, lack of physical activity, and the increased intake of alcohol, particularly among the young population. Moreover, the growing preference for minimally invasive (MI) procedures is also providing impetus to the market growth as they ensure a fast recovery. The vascular stents market is further supported by several factors such as minimised bleeding, low risk of infection, and low cost of the product in comparison to conventional surgical methods.

Competitive Landscape 

The report gives a detailed analysis of the following key players in the global vascular stents market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Abbott Laboratories
• Boston Scientific Corporation
• Biotronik, Inc.
• MicroPort Scientific Corporation
• B. Braun Melsungen AG
• Terumo Corporation
• Meril Life Sciences Pvt. Ltd.
• Medtronic
• BD
• Biosensors International Group, Ltd.
• Lepu Medical Technology
• Koninklijke Philips N.V.
• Teleflex Incorporated.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report